Skip to main content
Premium Trial:

Request an Annual Quote

Sage Bionetworks, Ingenuity Agree to Share Pathway Data, Algorithms


Ingenuity Systems said this week that it is collaborating with Sage Bionetworks to improve the non-profit's predictive disease networks.

Under the collaboration, Sage will use the company's Ingenuity Pathway Analysis software and Ingenuity Knowledge Base to improve its predictive disease networks. In addition, Sage's web portal will link out to the Ingenuity Knowledge Base and to IPA, and Sage's content, algorithms, and predictive disease networks will be made available within Ingenuity products like IPA.

Ingenuity said that the collaboration will be of particular interest to researchers "who are working to understand the complex developments in the diagnosis, treatment, and etiology of diseases." In particular, using Sage's content and algorithms within IPA will enable users "to more rapidly identify and prioritize therapeutic targets for drug development and assess toxicity of potential drug candidates," the company said.

The collaboration with Sage marks the third partnership that Ingenuity has signed within the last month. In late October, the company announced that it was going to integrate IPA with TransMed Systems' XB Bio-Integration Suite (BI 10/22/2010). In early November, it announced an agreement with Geospiza to integrate IPA with Geospiza's Genesifter (BI 11/5/2010).

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.